Clinical Trial Study of Patients with Mesothelioma and Other Lung Cancers
Please note: This 2009 clinical trial profile is provided for informational purposes only. In order to obtain more details about this trial, contact the participating healthcare facilities listed at the bottom of this page.
If you are looking for an attorney because you or a loved one has been diagnosed with mesothelioma, asbestos-related lung cancer or asbestosis, our law firm can help. Please fill out the form on this page for a FREE review of your asbestos case.
The National Cancer Institute is currently recruiting patients to participate in a clinical study. The researchers are seeking patients diagnosed with mesothelioma or other forms of lung cancer, including non-small cell lung cancer, mediastinal or chest wall neoplasms or lung metastases from cancers of non-thoracic origin. The Institute is also recruiting patients with esophageal cancer for the study.
In this study, researchers will analyze the results of biopsies, blood tests and urine tests to determine the applicable suitability criteria for future lung cancer clinical trial studies.
The study is being conducted at the Warrant Grant Magnuson Clinical Center in Bethesda, Maryland. To obtain more information, contact the study’s investigative study chair, David S. Schrump, M.D. at this facility.
Weitz & Luxenberg is a leading plaintiffs' law firm that has represented people affected by mesothelioma for over 20 years. Men and women diagnosed with caused by asbestos exposure may be entitled to compensation from the companies responsible for their disease.
If you would like a free consultation or more information about your legal options, please complete the form below, and a representative of our law firm will contact you as soon as possible.

NYC-based study of two mesothelioma drugs: Eloxatin and Gemcitabine